The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells

被引:40
作者
Corpataux, JM
Naik, J
Porter, KE
London, NJM
机构
[1] Univ Leicester, Dept Surg, Leicester Royal Infirm, Leicester LE2 7LX, Leics, England
[2] Serv Chirurg Thorac & Vasc, Lausanne, Switzerland
关键词
intimal hyperplasia; invasion; migration; proliferation; saphenous vein; smooth muscle cell;
D O I
10.1016/j.jss.2005.05.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Intimal hyperplasia (IH) can occur after any vascular injury and results from smooth muscle cells (SMC) proliferation, migration, and invasion into the subintimal space. The purpose of this study was to investigate the effect of six different statins on the proliferation, migration, and invasion of human venous SMC. The statins were all used at their Cmax concentrations. SMCs were used to construct growth curves in the presence of 10% fetal calf serum or 10% fetal calf serum supplemented with the six statins. Migration and invasion experiments were performed using modified Boyden chambers. The invasion experiments were performed using Matrigel coated plates. We found that all of the statins significantly inhibited SMC proliferation compared to the platelet-derived growth factor control (ranging from fluvastatin 33% of control to pravastatin 72% of control, P = 0.03). SMC migration through uncoated polycarbonate membranes in presence of the six statins was significantly reduced (ranging from lovastatin 43% to pravastatin 57% of control, P = 0.006). All six statins also significantly reduced SMC invasion (ranging from fluvastatin 65% to simvastatin 87% of control, P = 0.002). We conclude that the inhibitory effect of statins on SMC proliferation, migration, and invasion is a class, rather than drug specific effect. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 20 条
[1]   Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways [J].
Ai, S ;
Kuzuya, M ;
Koike, T ;
Asai, T ;
Kanda, S ;
Maeda, K ;
Shibata, T ;
Iguchi, A .
ATHEROSCLEROSIS, 2001, 155 (02) :321-327
[2]   Direct vascular effects of HMG-CoA reductase inhibitors [J].
Bellosta, S ;
Bernini, F ;
Ferri, N ;
Quarato, P ;
Canavesi, M ;
Arnaboldi, L ;
Fumagalli, R ;
Paoletti, R ;
Corsini, A .
ATHEROSCLEROSIS, 1998, 137 :S101-S109
[3]  
CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503
[4]   Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization [J].
Christenson, JT .
CARDIOVASCULAR SURGERY, 2001, 9 (01) :33-43
[5]  
Collins R, 2003, LANCET, V361, P2005
[6]   New insights into the pharmacodynamic and pharmacokinetic properties of statins [J].
Corsini, A ;
Bellosta, S ;
Baetta, R ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
PHARMACOLOGY & THERAPEUTICS, 1999, 84 (03) :413-428
[7]   PATHOPHYSIOLOGY OF VEIN GRAFT FAILURE - A REVIEW [J].
DAVIES, MG ;
HAGEN, PO .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (01) :7-18
[8]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[9]   Effect of Simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction [J].
Hagenaars, T ;
Gussenhoven, EJ ;
van Sambeek, MRHM ;
Jukema, JW ;
Kranendonk, SE ;
Bom, N .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07) :774-776
[10]   Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (lipoprotein and coronary atherosclerosis study [LCAS]) [J].
Herd, JA ;
Ballantyne, CM ;
Farmer, JA ;
Ferguson, JJ ;
Jones, PH ;
West, S ;
Gould, KL ;
Gotto, AM .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (03) :278-286